Evidence map›Paper›PMID 27930607›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2017

Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.

Jennifer F Morton, Connie Celum, John Njoroge, Agnes Nakyanzi, Imeldah Wakhungu, Edna Tindimwebwa, Snaidah Ongachi, Eric Sedah, Emmanuel Okwero, Kenneth Ngure and 6 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Jennifer F MortonDepartments of *Global Health; †Epidemiology; ‡Medicine, University of Washington, Seattle, WA; §Centres for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya; ‖Infectious Disease Institute, Makerere University, Kampala, Uganda; ¶Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya; #Kabwohe Clinical Research Center, Kabwohe, Uganda; **Department of Public and Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya; and ††Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Connie Celum
John Njoroge
Agnes Nakyanzi
Imeldah Wakhungu
Edna Tindimwebwa
Snaidah Ongachi
Eric Sedah
Emmanuel Okwero
Kenneth Ngure
Josephine Odoyo
Nulu Bulya
Jessica E Haberer
Jared M Baeten
Renee Heffron
Partners Demonstration Project Team
Kenya Medical Research Institute · KEMakerere University · UGUniversity of Washington · USJoint Clinical Research Centre · UGJomo Kenyatta University of Agriculture and Technology · KEMassachusetts General Hospital · US

Funding

Optimizing Antiretroviral-Based HIV Prevention for HIV Serodiscordant CouplesR01MH095507 · NIMH · UNIVERSITY OF WASHINGTON · PI BAETEN, JARED · 2011 to 2020
$6.1M
Antiretroviral periconception HIV prevention for HIV discordant couplesR00HD076679 · NICHD · UNIVERSITY OF WASHINGTON · PI HEFFRON, RENEE A. · 2015 to 2017
$742k
NICHD NIH HHS R00 HD076679NIMH NIH HHS R01 MH095507
6 · The paper itself

Abstract

backgroundFor HIV-serodiscordant couples, integrated delivery of antiretroviral therapy (ART) for HIV-positive partners and time-limited pre-exposure prophylaxis (PrEP) for negative partners virtually eliminates HIV transmission. Standardized messaging, sensitive to the barriers and motivators to HIV treatment and prevention, is needed for widespread scale-up of this approach.

methodsWithin the Partners Demonstration Project, a prospective interventional project among 1013 serodiscordant couples in Kenya and Uganda, we offered ART to eligible HIV-positive partners and PrEP to HIV-negative partners before ART initiation and through the HIV-positive partner's first 6 months of ART use. We conducted individual and group discussions with counseling staff to elicit the health communication framework and key messages about ART and PrEP that were delivered to couples.

resultsCounseling sessions for serodiscordant couples about PrEP and ART included discussions of HIV serodiscordance, PrEP and ART initiation and integrated use, and PrEP discontinuation. ART messages emphasized daily, lifelong use for treatment and prevention, adherence, viral suppression, resistance, side effects, and safety of ART during pregnancy. PrEP messages emphasized daily dosing, time-limited PrEP use until the HIV-positive partner sustained 6 months of high adherence to ART, adherence, safety during conception, side effects, and other risks for HIV.

conclusionsCounseling messages for HIV-serodiscordant couples are integral to the delivery of time-limited PrEP as a "bridge" to ART-driven viral suppression. Their incorporation into programmatic scale-up will maximize intervention impact on the global epidemic.

Indexed as

CounselingPre-Exposure ProphylaxisSexual PartnersAdolescentAdultAnti-HIV AgentsCost-Benefit AnalysisFemaleHealth Care CostsHIV InfectionsHIV SeronegativityHIV SeropositivityHumansKenyaMalePatient ComplianceAnti-HIV Agents

Identifiers

PMID27930607
PMCPMC5147040
OpenAlexW2560021666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.